Created in 1992, Eurofins bioskin is a leading full-service CRO specialized in dermatology and aesthetics which plans and conducts clinical trials for pharmaceuticals, medical devices, food supplements and advanced/professional cosmetics. Headquartered in Germany Eurofins bioskin offers dermatologic consulting and regulatory, early phase safety and Proof-of-Concept studies, vasoconstrictor assays and global Phase II-IV trials for NCEs, new formulations with known actives and generics. We maintain a large database of healthy volunteers and patients profiled for skin condition and disease, assuring fast, reliable recruitment. A core expertise is the development of innovative test models, integrating biophysical measurement methods to deliver objective data about skin function and structure to support traditional clinical endpoints. In addition, through an extensive network of dermatologists and university hospitals Eurofins bioskin has excellent access to patients outside of Germany, including challenging to find and severely diseased patients. Eurofins bioskin partners with select, reliable partners in the US, Latin America, EU, Eastern Europe and South Africa for the conduct of pivotal multinational studies. Since August 2021 bioskin is part of the Eurofins network of companies.